 |
|
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2020;26(4):662-669. Published online 2020 Sep 25 DOI: https://doi.org/10.3350/cmh.2020.0163
|
|
Citations to this article as recorded by
 Dietary and nutrition considerations in caring for patients with nonalcoholic fatty liver disease: Updates for the practicing clinician
Carolyn Newberry, Sonal Kumar
Nutrition in Clinical Practice.2023; 38(1): 70. CrossRef The role of predicted lean body mass and fat mass in non-alcoholic fatty liver disease in both sexes: Results from a secondary analysis of the NAGALA study
Maobin Kuang, Ruijuan Yang, Qiyang Xie, Nan Peng, Song Lu, Guobo Xie, Shuhua Zhang, Yang Zou
Frontiers in Nutrition.2023;[Epub] CrossRef Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(1): 179. CrossRef The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clinical and Molecular Hepatology.2023; 29(Suppl): S261. CrossRef Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population
Jiawang Zou, Hailan Xiong, Huimin Zhang, Chong Hu, Song Lu, Yang Zou
BMC Gastroenterology.2022;[Epub] CrossRef Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease
Yang Zou, Chong Hu, Maobin Kuang, Yuliang Chai
BMC Gastroenterology.2022;[Epub] CrossRef MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 150. CrossRef Association between physical activity and insulin resistance using the homeostatic model assessment for insulin resistance independent of waist circumference
Tae Kyung Yoo, Byeong Kil Oh, Mi Yeon Lee, Ki-Chul Sung
Scientific Reports.2022;[Epub] CrossRef Effects of moderate ethanol consumption as a function of n-6:n-3 dietary ratio on lipid profile, inflammation, and liver function in mice
Kristine Giltvedt, Luciano S. Voutour, Brianna Tursellino, Alexandra Zella, Susan M. Brasser, Mee Young Hong
International Journal of Cardiology Cardiovascular Risk and Prevention.2022; 14: 200132. CrossRef Association between hypertriglyceridemic-waist phenotype and non-alcoholic fatty liver disease: a general population-based study
Ming Yang, Yaqin Xu, Chong Hu, Shuhua Zhang, Maobin Kuang, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population
Maobin Kuang, Song Lu, Qiyang Xie, Nan Peng, Shiming He, Changhui Yu, Jiajun Qiu, Guotai Sheng, Yang Zou
BMC Gastroenterology.2022;[Epub] CrossRef Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population
Song Lu, Maobin Kuang, Jinjing Yue, Chong Hu, Guotai Sheng, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR‐mediated inhibition of autophagy under hyperlipidemic conditions
Heeseung Oh, Seung Yeon Park, Wonjun Cho, A. M. Abd El‐Aty, Ahmet Hacimuftuoglu, Chang Hyuk Kwon, Ji Hoon Jeong, Tae Woo Jung
Journal of Cellular Physiology.2022; 237(11): 4226. CrossRef The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
Maobin Kuang, Guotai Sheng, Chong Hu, Song Lu, Nan Peng, Yang Zou
Lipids in Health and Disease.2022;[Epub] CrossRef Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clinical and Molecular Hepatology.2022; 28(4): 790. CrossRef Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population
Rongsheng Wang, Longlong DAI, Yanjia Zhong, Guobo Xie
Lipids in Health and Disease.2021;[Epub] CrossRef Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study
Yang Zou, Jianyun Lan, Yanjia Zhong, Shuo Yang, Huimin Zhang, Guobo Xie
Lipids in Health and Disease.2021;[Epub] CrossRef The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease
Guotai Sheng, Song Lu, Qiyang Xie, Nan Peng, Maobin Kuang, Yang Zou
Lipids in Health and Disease.2021;[Epub] CrossRef Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)
Wayne Eskridge, John M. Vierling, Wayne Gosbee, Gabriella A. Wan, May-Linh Hyunh, Henry E. Chang, Daisuke Tokuhara
PLOS ONE.2021; 16(11): e0260320. CrossRef
|